Simplex Trading’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-22,900
| Closed | -$879K | – | 10304 |
|
|
2023
Q2 | $879K | Buy |
22,900
+3,400
| +17% | +$87.3K | ﹤0.01% | 2724 |
|
|
2023
Q1 | $451K | Buy |
19,500
+18,900
| +3,150% | +$451K | ﹤0.01% | 3385 |
|
|
2022
Q4 | $15K | Buy |
+600
| New | +$13.3K | ﹤0.01% | 7188 |
|
|
2022
Q3 | – | Sell |
-3,400
| Closed | -$59K | – | 11248 |
|
|
2022
Q2 | $59K | Sell |
3,400
-9,100
| -73% | -$143K | ﹤0.01% | 6280 |
|
|
2022
Q1 | $204K | Buy |
12,500
+9,800
| +363% | +$133K | ﹤0.01% | 5125 |
|
|
2021
Q4 | $44K | Buy |
2,700
+1,500
| +125% | +$21.4K | ﹤0.01% | 7437 |
|
|
2021
Q3 | $16K | Hold |
1,200
| – | – | ﹤0.01% | 8637 |
|
|
2021
Q2 | $16K | Buy |
+1,200
| New | +$19.2K | ﹤0.01% | 8795 |
|
|
2021
Q1 | – | Sell |
-26
| Closed | -$41K | – | 10363 |
|
|
2020
Q4 | $41K | Buy |
26
+19
| +271% | +$287 | ﹤0.01% | 6391 |
|
|
2020
Q3 | $1K | Sell |
7
-3
| -30% | -$40 | ﹤0.01% | 7627 |
|
|
2020
Q2 | $11K | Buy |
+10
| New | +$138 | ﹤0.01% | 6623 |
|
|
2019
Q3 | – | Sell |
-2
| Closed | -$1K | – | 8082 |
|
|
2019
Q2 | $1K | Hold |
2
| – | – | ﹤0.01% | 6938 |
|
|
2019
Q1 | $3K | Buy |
+2
| New | +$35 | ﹤0.01% | 6717 |
|
|
2018
Q4 | – | Sell |
-4
| Closed | -$15K | – | 8055 |
|
|
2018
Q3 | $15K | Buy |
+4
| New | +$128 | ﹤0.01% | 6197 |
|
|
2018
Q1 | – | Sell |
-21
| Closed | -$7K | – | 7083 |
|
|
2017
Q4 | $7K | Buy |
+21
| New | +$917 | ﹤0.01% | 4249 |
|
|
2017
Q2 | – | Sell |
-8
| Closed | -$1K | – | 6995 |
|
|
2017
Q1 | $1K | Buy |
+8
| New | +$452 | ﹤0.01% | 5864 |
|
|
2016
Q3 | – | Sell |
-74
| Closed | -$17K | – | 6650 |
|
|
2016
Q2 | $17K | Buy |
74
+32
| +76% | +$1.94K | ﹤0.01% | 3065 |
|
|
2016
Q1 | $39K | Buy |
42
+36
| +600% | +$2.91K | ﹤0.01% | 2181 |
|
|
2015
Q4 | $7K | Buy |
6
+5
| +500% | +$679 | ﹤0.01% | 3661 |
|
|
2015
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 5217 |
|
|
2015
Q2 | $1K | Buy |
+1
| New | +$165 | ﹤0.01% | 4865 |
|
Simplex Trading's KDNY Position: Q3 2023 in Review
Simplex Trading sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 25,538 shares — an estimated $981K sold.
Simplex Trading first reported a position in KDNY in Q2 2015 and held it in 17 quarters. The position peaked at $981K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- Simplex Trading reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Simplex Trading sold 25,538 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $981K.
- Simplex Trading first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 17 quarters.
- Simplex Trading's Chinook Therapeutics, Inc. Common Stock position peaked at $981K in Q2 2023.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on Simplex Trading's 13F filing for Q3 2023, filed 1 Nov 2023.